Inflammatory disease | Restoring vision | Colon mucus

National Institutes of Health (NIH) sent this bulletin at 11/03/2020 01:50 PM EST

Having trouble viewing this email? View it as a Web page.

November 3, 2020 Edition

COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.

New inflammatory disease discovered

Using a genomic approach, researchers identified a new inflammatory disorder, called VEXAS, in men with diverse symptoms.

Gene therapy with novel protein restores vision in mice

Researchers restored vision in blind mice by using gene therapy to add a novel light-sensing protein to cells in the retina.

How mucus in the colon prevents inflammation and injury

A study in mice showed how mucus production throughout the colon keeps gut bacteria isolated from intestinal tissue and helps prevent inflammation.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.